Terms: = Head and neck cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Diagnosis
7 results:
1. Rates of Thy 1-non-diagnostic thyroid fine needle aspiration using the UK Royal College of Pathologists Thy Terminology. A systematic review of the literature comparing patients who undergo rapid on-site evaluation and those who do not.
Poller DN; Doyle V; Trimboli P; Bongiovanni M
Cytopathology; 2020 Nov; 31(6):502-508. PubMed ID: 32003044
[TBL] [Abstract] [Full Text] [Related]
2. Genetic variants in DNA repair predicts the survival of patients with esophageal cancer.
Lee JM; Yang PW; Yang SY; Chuang TH; Tung EC; Chen JS; Huang PM; Lee YC
Ann Surg; 2011 May; 253(5):918-27. PubMed ID: 21490450
[TBL] [Abstract] [Full Text] [Related]
3. Polymorphisms of the DNA repair genes XRCC1 and ercc4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population.
Krupa R; Kasznicki J; Gajęcka M; Rydzanicz M; Kiwerska K; Kaczmarczyk D; Olszewski J; Szyfter K; Blasiak J; Morawiec-Sztandera A
Exp Oncol; 2011 Mar; 33(1):55-6. PubMed ID: 21423097
[TBL] [Abstract] [Full Text] [Related]
4. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
[TBL] [Abstract] [Full Text] [Related]
5. Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma.
Sedda AF; Rossi G; Cipriani C; Carrozzo AM; Donati P
Clin Exp Dermatol; 2008 Nov; 33(6):745-9. PubMed ID: 18681873
[TBL] [Abstract] [Full Text] [Related]
6. Surgeon-performed ultrasound in the management of thyroid malignancy.
Solorzano CC; Carneiro DM; Ramirez M; Lee TM; Irvin GL
Am Surg; 2004 Jul; 70(7):576-80; discussion 580-2. PubMed ID: 15279178
[TBL] [Abstract] [Full Text] [Related]
7. Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer: a novel molecular marker?
Roddiger SJ; Renneberg H; Martin T; Tunn UW; Zamboglou N; Kurek R
J Cancer Res Clin Oncol; 2003 Jan; 129(1):29-34. PubMed ID: 12618898
[TBL] [Abstract] [Full Text] [Related]
